Published in Cancer on May 01, 1989
Parathyroid hormone related protein in hypercalcaemia of Hodgkin's disease. J Clin Pathol (1992) 0.97
Hypercalcaemia in Hodgkin's disease related to prostaglandin synthesis. J Clin Pathol (1994) 0.78
Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia. Postgrad Med J (1990) 0.75
Nodular Lymphocyte Predominant Hodgkin's Lymphoma Presenting as Severe Hypercalcaemia: A Case Report. Sultan Qaboos Univ Med J (2007) 0.75
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol (2001) 5.46
The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol (1995) 5.36
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst (2001) 4.69
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. J Clin Oncol (1990) 3.20
Second cancers following pediatric Hodgkin's disease. J Clin Oncol (1998) 3.19
The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med (1984) 2.95
The Intergroup Rhabdomyosarcoma Study-II. Cancer (1993) 2.77
Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol (1993) 2.49
The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma (2001) 2.10
Isolated granulomas in Hodgkin's disease. N Engl J Med (1970) 2.10
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol (2001) 2.06
Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys (1990) 1.91
Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann Intern Med (1982) 1.79
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med (1997) 1.70
Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Case study: suprasellar germinoma presenting with psychotic and obsessive-compulsive symptoms. J Am Acad Child Adolesc Psychiatry (2000) 1.59
Parameningeal rhabdomyosarcoma: results of an international workshop. Int J Radiat Oncol Biol Phys (1996) 1.50
Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med (1981) 1.49
Second cancers after Hodgkin's disease in childhood. N Engl J Med (1996) 1.49
Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol (1999) 1.44
Visual results and ocular complications following radiotherapy for retinoblastoma. Arch Ophthalmol (1978) 1.43
Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. JAMA (1982) 1.42
High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival. Int J Radiat Oncol Biol Phys (1996) 1.41
Posterior ocular abnormalities after irradiation for retinoblastoma: a histopathological study. Br J Ophthalmol (1980) 1.41
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy. Int J Radiat Oncol Biol Phys (1993) 1.40
A study of the nutritional status of pediatric cancer patients. Am J Dis Child (1981) 1.33
Epithelioid granulomas associated with Hodgkin's disease: clinical correlations in 55 previously untreated patients. Cancer (1978) 1.33
Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol (1986) 1.32
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Hematol Oncol (2001) 1.29
Rhabdomyosarcoma of head and neck in children. Combination treatment by surgery, irradiation, and chemotherapy. Cancer (1973) 1.29
Astrocytoma in children: 14 years' experience at Stanford University Medical Center. J Clin Oncol (1988) 1.27
Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol (1997) 1.25
Letter: Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med (1974) 1.23
Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet (1994) 1.23
Histiocytic malignancies. Morphologic, immunologic, and enzymatic heterogeneity. Am J Surg Pathol (1984) 1.21
Treatment results among adults with childhood tumors: a 20-year experience. Int J Radiat Oncol Biol Phys (1989) 1.15
Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol (1995) 1.14
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood (1993) 1.13
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial. J Clin Oncol (1998) 1.12
A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol (1993) 1.12
What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer (2001) 1.11
Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep (1982) 1.10
Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. Blood (1984) 1.10
Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol (1999) 1.09
Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood (1997) 1.09
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Ann Intern Med (1992) 1.07
Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. Blood (1991) 1.06
Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer (1984) 1.05
Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol (1994) 1.04
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol (1987) 1.03
Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys (1989) 1.02
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (2000) 1.01
Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood (1992) 0.99
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. Med Pediatr Oncol (1994) 0.98
Langerhans' cell histiocytosis of the head and neck. Laryngoscope (1987) 0.97
The treatment of malignant histiocytosis. Blood (1984) 0.97
Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys (1993) 0.96
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood (1995) 0.96
Hodgkin's disease in homosexual men with generalized lymphadenopathy. Ann Intern Med (1985) 0.95
Postirradiation sarcoma in retinoblastoma. Induction or predisposition? Arch Otolaryngol Head Neck Surg (1988) 0.95
Special nutritional needs of children with malignancies: a review. JPEN J Parenter Enteral Nutr (1990) 0.94
Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg (2001) 0.94
Treatment of pediatric Hodgkin's lymphoma. Semin Hematol (1999) 0.94
Clinical and phenotypic diversity of T cell lymphomas. Blood (1986) 0.94
Nutritional consequences of radiotherapy. Cancer Res (1977) 0.93
Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial. Cancer (1985) 0.93
Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure? J Neurosurg (1991) 0.92
Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (2001) 0.92
Protective effect of hyperthermia against the cytotoxicity of actinomycin D on Chinese hamster cells. Cancer Treat Rep (1978) 0.92
Soft-tissue sarcomas of the diaphragm: a report from the Intergroup Rhabdomyosarcoma Study Group from 1972 to 1997. J Pediatr Hematol Oncol (2000) 0.92
Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer (1976) 0.91
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. Biol Blood Marrow Transplant (2001) 0.91
Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys (1999) 0.90
Role of beam orientation optimization in intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2001) 0.90
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood (1989) 0.90
Cranial nerve involvement in children with leukemia and lymphoma. J Clin Oncol (1983) 0.89
Radiation enteritis in children. A retrospective review, clinicopathologic correlation, and dietary management. Cancer (1975) 0.89
Late relapse among patients treated for Hodgkin's disease. Ann Intern Med (1985) 0.89
Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. J Clin Oncol (2001) 0.88
Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation. Int J Cell Cloning (1986) 0.88
Characterization of postsplenectomy bacteremia among patients with and without lymphoma. N Engl J Med (1972) 0.88
Second cancers in long-term survivors of Ewing's sarcoma. Clin Orthop Relat Res (1992) 0.88
Alterations of nutritional status: impact of chemotherapy and radiation therapy. Cancer (1979) 0.88
Management of the pregnant patient with Hodgkin's disease. Ann Intern Med (1981) 0.88
Herpes zoster and varicella infections in children with Hodgkin's disease: an analysis of contributing factors. Cancer (1978) 0.87
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87
Radiation therapy for benign disease of the orbit. Semin Radiat Oncol (1999) 0.87
Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. Int J Radiat Oncol Biol Phys (1997) 0.87
Autologous hematopoietic cell transplantation in Hodgkin's disease. Biol Blood Marrow Transplant (2000) 0.87
Bacterial infections in pediatric Hodgkin's disease: relationship to radiotherapy, chemotherapy and splenectomy. Cancer (1978) 0.86
Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomas. J Clin Oncol (1989) 0.86
Rhabdomyosarcoma: the Stanford experience using a TNM staging system. J Clin Oncol (1986) 0.86